Field theory: The transference-countertransference relationship and second look.

Autor: de León de Bernardi B; Full Member of the Uruguayan Psychoanalytic Association, Montevideo, Uruguay.

Publikováno v: The International journal of psycho-analysis [Int J Psychoanal] 2023 Aug; Vol. 104 (4), pp. 737-754. Date of Electronic Publication: 2023 Sep 18.

Treatment of localised resectable neuroblastoma. Results of the LNESG1 study by the SIOP Europe Neuroblastoma Group.

Autor: De Bernardi, B.¹ brunodebernardi@ospedale-gaslini.ge.it, Mosseri, V.², Rubie, H.³, Castel, V.⁴, Foot, A.⁵, Ladenstein, R.⁶, Laureys, G.⁷, Beck-Popovic, M.⁸, De Lacerda, A. F.⁹, Pearson, A. D. J.¹⁰, De Kraker, J.¹¹, Ambros, P. F.¹², De Rycke, Y.², Conte, M.¹, Bruzzi, P.¹³, Michon, J.¹⁴, SIOP Europe Neuroblastoma Group (CORPORATE AUTHOR)

Publikováno v: British Journal of Cancer. 9/22/2008, Vol. 99 Issue 7, p1027-1033. 7p. 5 Charts, 1 Graph.

A Review of Infants With Localized Neuroblastoma That Evolve to Stage 4s Disease.

Autor: Caroleo AM; Departments of Hematology/Oncology., De Bernardi B; Departments of Hematology/Oncology., Avanzini S; Surgery., Gigliotti AR; Epidemiology and Biostatistics Unit., Muraca M; Departments of Hematology/Oncology., Pota E; Hematology/Oncology Unit, Pediatric Department, Vanvitelli University, Napoli., Provenzi M; Department of Pediatrics, Civic Hospital, Bergamo, Italy., Mazzocco K; Pathology Unit, IRCCS Istituto Giannina Gaslini, Genova., Sementa AR; Pathology Unit, IRCCS Istituto Giannina Gaslini, Genova., Granata C; Radiology., Sorrentino S; Departments of Hematology/Oncology.

Publikováno v: Journal of pediatric hematology/oncology [J Pediatr Hematol Oncol] 2020 Aug; Vol. 42 (6), pp. e483-e487.

Presenting features of neuroblastoma with spinal canal invasion. A prospective study of the International Society of Pediatric Oncology Europe - Neuroblastoma (SIOPEN).

Autor: Sorrentino S; Paediatric Oncology Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy., Ash S; Joan and Sanford Weill Paediatric Haematology Oncology and Bone Marrow Transplantation Division, Ruth and Bruce Rappaport Faculty of Medicine, Technion Israel Institute of Technology, Haifa, Israel., Haupt R; DOPO Clinic, IRCCS Istituto Giannina Gaslini, Genova, Italy., Plantaz D; Department de Paediatrics, Hôpital Couple Enfants, CHU Grenoble, Grenoble, France., Schiff I; Department de Paediatrics, Hôpital Couple Enfants, CHU Grenoble, Grenoble, France., Hero B; Department of Paediatric Haematology and Oncology, Children's Hospital, University of Cologne, Cologne, Germany., Simon T; Department of Paediatric Haematology and Oncology, Children's Hospital, University of Cologne, Cologne, Germany., Kachanov D; Department of Clinical Oncology, Dmitry Rogachev National Medical Research Center of Paediatric Haematology, Oncology and Immunology, Moscow, Russia., Shamanskaya T; Department of Clinical Oncology, Dmitry Rogachev National Medical Research Center of Paediatric Haematology, Oncology and Immunology, Moscow, Russia., Kraal K; Princess Màxima Centre for Paediatric Oncology, Utrecht, Netherlands., Littooij A; Princess Màxima Centre for Paediatric Oncology, Utrecht, Netherlands., Wieczoreck A; Paediatric Oncology and Haematology Department, Institute of Paediatrics, Jagiellonian University, Krakow, Poland., Balwierz W; Paediatric Oncology and Haematology Department, Institute of Paediatrics, Jagiellonian University, Krakow, Poland., Laureys G; Department of Paediatric Haematology-Oncology, Prinses Elisabeth Kinderziekenhuis, University Hospital, Gent, Belgium., Trager C; Women's and Childrens Health, Karolinska Institutet, Stockholm, Sweden., Sertorio F; Radiology Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy., Erminio G; Scientific Directorate, IRCCS Istituto Giannina Gaslini, Genova, Italy., Fragola M; Scientific Directorate, IRCCS Istituto Giannina Gaslini, Genova, Italy., Beck Popovic M; Centre Hospitalier Universitaire Vaudois, Unité d'Hémato-Oncologie Pédiatrique, Lausanne, Switzerland., De Bernardi B; Paediatric Oncology Unit, IRCCS Istituto Giannina Gaslini, Genova, Italy., Trahair T; Kids Cancer Center, Sydney Children's Hospital, Randwick, NSW, Australia.; Children's Cancer Institute, Lowy Cancer Research Centre, University of New South Wales, Kensington, NSW, Australia.; School of Women's and Children's Health, University of New South Wales, Kensington, NSW, Australia.

Publikováno v: Frontiers in pediatrics [Front Pediatr] 2022 Oct 10; Vol. 10, pp. 1023498. Date of Electronic Publication: 2022 Oct 10 (Print Publication: 2022).

Age-dependency of the prognostic impact of tumor genomics in localized resectable MYCN non-amplified neuroblastomas Report from the SIOPEN Biology Group on the LNESG Trials

Autor: Ambros, I.M., Tonini, G.P., Gross, N., Mosseri, V., Pötschger, U., Beiske, K., Berbegall, A.P., Bénard, J., Bown, N., Caron, H., Combaret, V., Couturier, J., Defferrari, R., Delattre, O., Jeison, M., Kogner, P., Lunec, J., Marques, B., Martinsson, T., Mazzocco, K., Noguera, R., Schleiermacher, G., Valent, A., Van Roy, N., Villamon, E., Janousek, D., Pribill, I., Glogova, E., Attiyeh, E.F., Hogarty, M.D., Monclair, T., Holmes, K., Valteau-Couanet, D., Pearson ADJ, A.D.J., Castel, V., Tweddle, D.A., Park, J.R., Cohn, S., Ladenstein, R., Beck-Popovic, M., De Bernardi, B., Michon, J., Ambros, P.F.

BACKGROUND: Biology based treatment reduction, i.e. surgery alone also in case of not totally resected tumors, was advised in neuroblastoma patients with localized resectable disease without MYCN amplification. However, whether the genomic background

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2016::66b18bf7b74b4a5d7ecf2168fe1bbcf4
https://hdl.handle.net/10400.18/5899